MENU
ENTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Entera Bio (ENTX) Ownership - Who owns Entera Bio?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
81.77M
P/E Ratio
N/A
Total Cash
6.92M
Projected Growth
N/A
Total Debt
309K
Revenue
99K
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
ENTX
Capitalization
81.8M
P/E Ratio
N/A
Risk (Beta)
2.00
Dividend Yield
N/A
Total Cash
6.92M
Total Cash/Share
0.19
Total Debt
309K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
99K
ROE
N/A
Book Value
6.45M
P/B Ratio
12.67
Cash Flow
N/A
Earnings
-0.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
6.61
Current Revenue Per Employee
2100.00
Dividends Per Share - Security
N/A
EBITDA
-9.16M
Float
N/A
Float - Current
N/A
Gross Income Margin
0.00
Revenue To Assets
-112.57
Shares Held By Institutions
33.4K
Shares Outstanding - Current
36.8M
Total Liabilities
1.29M
Total Volume MTD
N/A
Value
-1
Gain YTD
270.000
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of flu medicines
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com